{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:39:02Z","timestamp":1778870342572,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T00:00:00Z","timestamp":1336089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2334-12-107","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T16:14:23Z","timestamp":1345738463000},"source":"Crossref","is-referenced-by-count":26,"title":["Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study"],"prefix":"10.1186","volume":"12","author":[{"given":"Meaghan M","family":"Kall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel J","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen E","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony T","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham H","family":"Bothamley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,4]]},"reference":[{"key":"1932_CR1","volume-title":"Policy statement on preventive therapy against tuberculosis in people living with HIV","author":"WHO and UNAIDS","year":"1998","unstructured":"WHO and UNAIDS: Policy statement on preventive therapy against tuberculosis in people living with HIV. 1998, WHO, Geneva, Switzerland"},{"key":"1932_CR2","volume-title":"Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource constrained settings","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. 2010, Department of HIV\/AIDS, Stop TB Department, World Health Organization, Geneva, Switzerland"},{"key":"1932_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1183\/09031936.00114810","volume":"37","author":"M Sester","year":"2011","unstructured":"Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, Lipman M, Nemeth J, Ravn P, Winkler S, Huitric E, Sandgren A, Manissero D: Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2011, 37: 100-111.","journal-title":"Eur Respir J"},{"issue":"RR05","key":"1932_CR4","first-page":"1","volume":"59","author":"GH Mazurek","year":"2011","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K: Updated guidelines for using interferon-gamma release assays to detect Mycobacterium tuberculosis infection \u2013 United States 2010. MMWR. 2011, 59 (RR05): 1-25.","journal-title":"MMWR"},{"key":"1932_CR5","volume-title":"BHIVA guidelines for the treatment of TB\/HIV Co-infection 2010","author":"AL Pozniak","year":"2011","unstructured":"Pozniak AL, Collins S, Coyne KM, on behalf of the British HIV Association guidelines subcommittee: BHIVA guidelines for the treatment of TB\/HIV Co-infection 2010. 2011, BHIVA, London, UK"},{"issue":"7","key":"1932_CR6","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1086\/597351","volume":"48","author":"MC Aichelburg","year":"2009","unstructured":"Aichelburg MC, Rieger A, Breitenecker F, Pfiztershammer K, Tittes J, Eltz S, Aichelburg AC, Stingl G, Makristathis A, Kohrgruber N: Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis. 2009, 48 (7): 954-962.","journal-title":"Clin Infect Dis"},{"key":"1932_CR7","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1097\/QAD.0b013e3283188415","volume":"22","author":"C Stephan","year":"2008","unstructured":"Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, Oremek G, Rakus Z, Gottschalk R, Stark S, Brodt HR, Staszewski S: Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS. 2008, 22: 2471-2479.","journal-title":"AIDS"},{"key":"1932_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2334-9-15","volume":"9","author":"NJ Talati","year":"2009","unstructured":"Talati NJ, Seybold U, Humphrey B, Aina A, Tapia J, Weinfurter P, Albalak R, Blumberg HM: Poor concordance between interferon-ganna release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis. 2009, 9: 15-","journal-title":"BMC Infect Dis"},{"key":"1932_CR9","volume-title":"HIV in the United Kingdom: 2010 Report","author":"Health Protection Agency","year":"2010","unstructured":"Health Protection Agency: HIV in the United Kingdom: 2010 Report. 2010, HPA, London, UK"},{"key":"1932_CR10","volume-title":"Tuberculosis in the UK: Annual report on tuberculosis surveillance in the UK 2010","author":"Health Protection Agency","year":"2010","unstructured":"Health Protection Agency: Tuberculosis in the UK: Annual report on tuberculosis surveillance in the UK 2010. 2010, HPA, London, UK"},{"key":"1932_CR11","volume-title":"Global Tuberculosis Control: WHO Report 2010","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Global Tuberculosis Control: WHO Report 2010. 2010, WHO, Geneva, Switzerland"},{"issue":"Suppl 1","key":"1932_CR12","first-page":"30","volume":"9","author":"N Garrett","year":"2008","unstructured":"Garrett N, Kall M, Ashcroft T, Reeves I, Anderson J, Bothamley G: Evaluation of HIV-infected patients for latent or subclinical tuberculosis with the T-Spot.TB (Elispot) test. HIV Med. 2008, 9 (Suppl 1): 30-","journal-title":"HIV Med"},{"issue":"1","key":"1932_CR13","doi-asserted-by":"publisher","first-page":"e1000391","DOI":"10.1371\/journal.pmed.1000391","volume":"8","author":"H Getahun","year":"2011","unstructured":"Getahun H, Kittikraisak W, Heilig CM, et al: Development of a standardized screening rule for tuberculosis in people living with HIV in resource constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011, 8 (1): e1000391-","journal-title":"PLoS Med"},{"key":"1932_CR14","volume-title":"Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2006","unstructured":"National Institute for Health and Clinical Excellence (NICE): Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2006, Royal College of Physicians, London, UK"},{"key":"1932_CR15","first-page":"CD000171","volume":"1","author":"C Akolo","year":"2010","unstructured":"Akolo C, Adetifa I, Shepperd S, Volmink J: Treatment of latent tuberculosis in HIV infected persons. Cochrane Database Syst Rev. 2010, 1: CD000171-","journal-title":"Cochrane Database Syst Rev"},{"key":"1932_CR16","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1183\/09031936.00034007","volume":"30","author":"TW Rennie","year":"2007","unstructured":"Rennie TW, Bothamley GH, Engova D, Bates IP: Patient choice promotes adherence in preventive treatment for latent tuberculosis. Eur Respir J. 2007, 30: 728-735.","journal-title":"Eur Respir J"},{"key":"1932_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","volume":"283","author":"F Gordin","year":"2000","unstructured":"Gordin F, Chaisson RE, Matts JP, Miller C, de Lourdes Garcia M, Hafner R, Valdespino JL, Coberty J, Schecter M, Klukowicz AJ, Barry MA, O\u2019Brien RJ: Rifampin and pyrazinamide versus isoniazid for the prevention of tuberculosis in HIV-infected persons: an international randomized trial. JAMA. 2000, 283: 1445-1450.","journal-title":"JAMA"},{"key":"1932_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1086\/422645","volume":"39","author":"R van Hest","year":"2004","unstructured":"van Hest R, Baars H, Kik S, van Gerven P, Trompenaars MC, Kalisvaart M, Keizer S, Borgdorff M, Mensen M, Cobelens F: Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment. Clin Infect Dis. 2004, 39: 488-496.","journal-title":"Clin Infect Dis"},{"key":"1932_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/archinte.1997.00440230105014","volume":"157","author":"F Pulido","year":"1997","unstructured":"Pulido F, Pe\u0148a JM, Rubio R, Moreno S, Gonz\u00e1lez J, Guijarro C, Costa JR, V\u00e1zques JJ: Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients. Ann Intern Med. 1997, 157: 227-232.","journal-title":"Ann Intern Med"},{"key":"1932_CR20","volume-title":"Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2011","unstructured":"National Institute for Health and Clinical Excellence (NICE): Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2011, Royal College of Physicians, London, UK"},{"key":"1932_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1473-3099(09)70043-X","volume":"9","author":"MJA Reid","year":"2009","unstructured":"Reid MJA, Shah NS: Approaches to tuberculosis screening and diagnosis in people with HIV in resource limited settings. Lancet Infect Dis. 2009, 9: 173-184.","journal-title":"Lancet Infect Dis"},{"key":"1932_CR22","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1056\/NEJMoa0907488","volume":"362","author":"KP Cain","year":"2010","unstructured":"Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, Kanara N, Kimerling ME, Chheng P, Thai S, Sar B, Pharuphak P, Teeratakulpisam N, Phanuphak N, Dung NH, Quy HT, That LH, Varma JK: An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med. 2010, 362: 707-716.","journal-title":"N Engl J Med"},{"issue":"1","key":"1932_CR23","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1371\/journal.pmed.0040022","volume":"4","author":"EL Corbett","year":"2007","unstructured":"Corbett EL, Bandason T, Cheung YB, Munyatta S, Godfrey-Fausett P, Hayes R, Churchyard G, Butterworth A, Mason P: Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med. 2007, 4 (1): e22-","journal-title":"PLoS Med"},{"issue":"1","key":"1932_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1164\/rccm.200606-759OC","volume":"175","author":"R Wood","year":"2007","unstructured":"Wood R, Middelkoop K, Myer L, Grant AD, Whitelaw A, Lawn SD, Kaplan G, Huebner R, McIntyre J, Bekker L-G: Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med. 2007, 175 (1): 87-93.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1932_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1148\/radiology.193.1.7916467","volume":"193","author":"SD Greenberg","year":"1994","unstructured":"Greenberg SD, Frager D, Suster B, Walker S, Stavropoulos C, Rothpearl A: Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance). Radiology. 1994, 193 (1): 115-119.","journal-title":"Radiology"},{"issue":"2","key":"1932_CR26","first-page":"113","volume":"5","author":"NJ Hargreaves","year":"2001","unstructured":"Hargreaves NJ, Kadzakumanja O, Phiri S, Nyangulu DS, Salaniponi FML, Harries AD, Squire SB: What causes smear-negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence?. Int J Tuberc Lung Dis. 2001, 5 (2): 113-122.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"1932_CR27","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1086\/429825","volume":"40","author":"L Mtei","year":"2005","unstructured":"Mtei L, Matee M, Herfort O, Bakari M, Horsburgh CR, Waddell R, Cole BF, Vuola JM, Tvaroha S, Kreisworth B, Pallangyo K, von Reyn CF: High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis. 2005, 40 (10): 1500-1507.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1932_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1473-3099(09)70326-3","volume":"10","author":"K Kranzer","year":"2010","unstructured":"Kranzer K, Houben RM, Glynn JR, Bekker LG, Wood R, Lawn SD: Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis. 2010, 10 (2): 93-102.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"1932_CR29","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1086\/656282","volume":"51","author":"IV Bassett","year":"2010","unstructured":"Bassett IV, Wang B, Chetty S, et al: Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis. 2010, 51 (7): 823-829.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1932_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1183\/09031936.00058911","volume":"39","author":"MX Rangaka","year":"2012","unstructured":"Rangaka MX, Gideon HP, Wilkisnon KA, Pai M, Mwansa-Kambafilwe J, Maartens G, Glynn JR, Boulle A, Fielding K, Goliath R, Titus R, Mathee S, Wilkinson RJ: No discriminatory value of interferon-gamma release assays added to smear negative HIV-tuberculosis algorithms. Eur Respir J. 2012, 39 (1): 163-171.","journal-title":"Eur Respir J"},{"key":"1932_CR31","volume-title":"Cochrane Database Syst Rev","author":"J Volmink","year":"2004","unstructured":"Volmink J, Woldehanna S: Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2004, CD000171: 10.1002\/14651858.CD0000171.pub2."},{"key":"1932_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1183\/09031936.00115110","volume":"37","author":"R Diel","year":"2010","unstructured":"Diel R, Goletti D, Ferrara C, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger J-P, Sandgren A, Manissero D: Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2010, 37: 88-99.","journal-title":"Eur Respir J"},{"key":"1932_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","volume":"56","author":"A Cattamanchi","year":"2011","unstructured":"Cattamanchi A, Smith R, Steingert KR, Metcalfe JZ, Date A, Coleman C, Marston BJ, Huang L, Hopewell PC, Pai M: Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2011, 56: 230-238.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"1932_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1164\/rccm.200909-1355OC","volume":"182","author":"CR Horsburgh","year":"2010","unstructured":"Horsburgh CR, O\u2019Donnell M, Chamblee S, Moreland JL, Johnson J, Marsh BJ, Narita M, Johnson LS, von Reyn CF: Revisiting rates of reactivation tuberculosis: a population-based approach. Am J Respir Crit Care Med. 2010, 182 (3): 420-425.","journal-title":"Am J Respir Crit Care Med"},{"issue":"18","key":"1932_CR35","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1097\/QAD.0b013e3283320dfd","volume":"23","author":"United Kingdom Collaborative HIV Cohort Study Group","year":"2009","unstructured":"United Kingdom Collaborative HIV Cohort Study Group: Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?. AIDS. 2009, 23 (18): 2507-2515.","journal-title":"AIDS"},{"issue":"7","key":"1932_CR36","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/QAD.0b013e32833849df","volume":"24","author":"CL van Halsema","year":"2010","unstructured":"van Halsema CL, Fielding KL, Chihota VN, Russell EC, Lewis JJ, Churchyard GJ, Grant AD: Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting. AIDS. 2010, 24 (7): 1051-1055.","journal-title":"AIDS"},{"issue":"12","key":"1932_CR37","first-page":"1352","volume":"12","author":"J Landry","year":"2008","unstructured":"Landry J, Menzies D: Preventive chemotherapy. Where has it got us? Where to go next?. Int J Tuberc Lung Dis. 2008, 12 (12): 1352-1364.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"1932_CR38","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1086\/427802","volume":"40","author":"J Ena","year":"2005","unstructured":"Ena J, Valls V: Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis. 2005, 40 (5): 670-676.","journal-title":"Clin Infect Dis"},{"key":"1932_CR39","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borison AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR, Chaisson RE, for the TB Trials Consortium PREVENT TB Study Team: Three months of rifapentine and isoniazid for latent tuberculosis infection. New Engl J Med. 2011, 365: 2155-2166.","journal-title":"New Engl J Med"},{"issue":"4","key":"1932_CR40","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1016\/j.ijid.2009.05.007","volume":"14","author":"J Li","year":"2010","unstructured":"Li J, Munsiff SS, Tarantino T, Dorsinville M: Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis. 2010, 14 (4): e292-e297.","journal-title":"Int J Infect Dis"},{"issue":"8","key":"1932_CR41","first-page":"927","volume":"13","author":"N A\u00eft-Khaled","year":"2009","unstructured":"A\u00eft-Khaled N, Alarcon E, Bissell K, et al: Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis. 2009, 13 (8): 927-935.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"1932_CR42","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3201\/eid1205.050681","volume":"12","author":"ME Balcells","year":"2006","unstructured":"Balcells ME, Thomas SL, Godfrey-Faussett P, Grant AD: Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg Infect Dis. 2006, 12 (5): 744-751.","journal-title":"Emerg Infect Dis"},{"key":"1932_CR43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/jac\/dkp237","volume":"64","author":"IL Bergval","year":"2009","unstructured":"Bergval IL, Schuitema AR, Klatser PR, Anthony RM: Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance. J Antimicrob Chemother. 2009, 64: 515-523.","journal-title":"J Antimicrob Chemother"},{"key":"1932_CR44","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/ng.811","volume":"43","author":"CB Ford","year":"2011","unstructured":"Ford CB, Lin PL, Chase MR, Shah RR, Iartchouk O, Galagan J, Mohaideen N, Ioerger TR, Sacchettini JC, Lipsitch M, Flynn JL, Fortune SM: Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet. 2011, 43: 482-486.","journal-title":"Nat Genet"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-107\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T05:13:56Z","timestamp":1548220436000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,4]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1932"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-107","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,4]]},"article-number":"107"}}